Abiopharma

🔍 Lane Raymond J. (Director)

Company: Hewlett Packard Enterprise Co (HPE)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Sold 14,500 shares of Common Stock at $23.98 per share (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 989,564.00 | transaction_form_type: 4
• Acquired 14,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F2: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects vested RSUs and rounded dividend equivalent rights previously reflected in column 9.